Paper-Based Analytical Devices for Cancer Liquid Biopsy

Area of Science:

• Biotechnology
• Medical Diagnostics
• Cancer Research

Background:

• Liquid biopsies represent a significant advancement in cancer diagnosis.
• Point of care (PoC) platforms offer rapid, on-site analysis, reducing turnaround time from sample collection to results.
• Integrating PoC platforms enhances the accessibility of liquid biopsy-based cancer detection for patients.

Purpose of the Study:

• To provide readers with a comprehensive understanding of selecting the optimal sensing platform for cancer diagnostics.
• To elucidate the factors influencing the choice of PoC platforms for detecting cancer-related biomarkers.
• To empower researchers and clinicians in making informed decisions for liquid biopsy applications.

Main Methods:

• This tutorial focuses on the principles and considerations for selecting sensing platforms.
• It reviews various sensing technologies applicable to biomarker detection in liquid biopsies.
• Key performance indicators and suitability for specific biomarkers are discussed.

Main Results:

• The selection of an ideal sensing platform depends on the specific cancer biomarker and desired PoC application.
• Different platforms offer varying levels of sensitivity, specificity, and speed.
• Understanding these trade-offs is crucial for effective implementation.

Conclusions:

• Choosing the right sensing platform is critical for the successful deployment of PoC liquid biopsy systems.
• Optimized platform selection can accelerate cancer diagnosis and improve patient outcomes.
• Further development in PoC technologies will enhance their role in personalized cancer care.